Access the full text.
Sign up today, get DeepDyve free for 14 days.
Friis-Moller, d'Arminio Monforte, El-Sadr, de Wit (2003)
Combination antiretroviral therapy and the risk of myocardial infarction
A. Lifson, Jacqueline Neuhaus, J. Arribas, M. Berg-Wolf, A. Labriola, T. Read (2010)
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.American journal of public health, 100 10
N. Friis‐Møller, P. Reiss, C. Sabin, R. Weber, A. Monforte, W. El-Sadr, R. Thiébaut, S. Wit, O. Kirk, E. Fontas, M. Law, A. Phillips, J. Lundgren (2007)
Class of antiretroviral drugs and the risk of myocardial infarction.The New England journal of medicine, 356 17
S. Johnsen, Sara Dolan, Kathleen Fitch, J. Kanter, L. Hemphill, Jean Connelly, R. Lees, Hang Lee, S. Grinspoon (2006)
Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.The Journal of clinical endocrinology and metabolism, 91 12
F. Visnegarwala, M. Maldonado, P. Sajja, Jennifer Minihan, M. Rodriguez‐Barradas, Oliver Ong, C. Lahart, M. Hasan, A. Balasubramanyam, A. White (2004)
Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.The Journal of infection, 49 4
J. Aberg, R. Zackin, S. Brobst, S. Evans, B. Alston, W. Henry, M. Glesby, F. Torriani, Yijun Yang, S. Owens, C. Fichtenbaum (2005)
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.AIDS research and human retroviruses, 21 9
J. Stockman (2006)
Mortality in Relation to Smoking: 50 Years' Observations on Male British DoctorsYearbook of Pediatrics, 2006
Jacqueline Neuhaus, D. Jacobs, J. Baker, A. Calmy, D. Duprez, A. Rosa, L. Kuller, S. Pett, M. Ristola, M. Ross, M. Shlipak, R. Tracy, J. Neaton (2010)
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.The Journal of infectious diseases, 201 12
L. Rosenberg, D. Kaufman, S. Helmrich, S. Shapiro (1985)
The risk of myocardial infarction after quitting smoking in men under 55 years of age.The New England journal of medicine, 313 24
L. Elzi, D. Spoerl, Jacqueline Voggensperger, D. Nicca, M. Simcock, H. Bucher, R. Spirig, M. Battegay (2005)
A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot StudyAntiviral Therapy, 11
C. Pablo, Samuel Orden, N. Apostolova, A. Blanquer, J. Esplugues, Á. Álvarez (2010)
Abacavir and didanosine induce the interaction between human leukocytes and endothelial cells through Mac-1 upregulationAIDS, 24
D. Périard, A. Telenti, P. Sudre, J. Cheseaux, P. Halfon, M. Reymond, S. Marcovina, M. Glauser, P. Nicod, R. Darioli, V. Mooser (1999)
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.Circulation, 100 7
C. Brothers, Jaime Hernandez, A. Cutrell, L. Curtis, M. Ait‐Khaled, S. Bowlin, S. Hughes, J. Yeo, D. Lapierre (2009)
Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult SubjectsJAIDS Journal of Acquired Immune Deficiency Syndromes, 51
Denise Cummins, Garry Trotter, M. Moussa, Geoff Turham (2005)
Smoking cessation for clients who are HIV-positive.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 20 12
C. Sabin, A. Montforte, N. Friis‐Møller, R. Weber, W. El-Sadr, P. Reiss, O. Kirk, P. Mercié, M. Law, S. Wit, C. Pradier, A. Phillips, J. Lundgren (2008)
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 7
M. Dubé, J. Stein, J. Aberg, C. Fichtenbaum, J. Gerber, K. Tashima, W. Henry, J. Currier, D. Sprecher, M. Glesby (2003)
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 5
J. Danesh, S. Kaptoge, A. Mann, N. Sarwar, A. Wood, Sara Angleman, Frances Wensley, J. Higgins, L. Lennon, G. Eiriksdottir, A. Rumley, P. Whincup, G. Lowe, V. Gudnason (2008)
Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLoS Medicine, 5
J. Sleasman, M. Goodenow (2003)
HIV-1 infectionThe Journal of Allergy and Clinical Immunology, 111
C. Sabin, S. Worm, R. Weber, P. Reiss, W. El-Sadr, F. Dabis, S. Wit, M. Law, A. Monforte, N. Friis‐Møller, O. Kirk, C. Pradier, I. Weller, A. Phillips, J. Lundgren (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaborationThe Lancet, 371
A. Richter, M. Pladevall, R. Manjunath, J. Lafata, H. Xi, Janine Simpkins, I. Brar, N. Markowitz, U. Iloeje, W. Irish (2005)
Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV‐infected patients: a retrospective cohort studyHIV Medicine, 6
V. Appay, J. Almeida, D. Sauce, B. Autran, L. Papagno (2007)
Accelerated immune senescence and HIV-1 infectionExperimental Gerontology, 42
L. Calza, R. Manfredi, B. Farneti, F. Chiodo (2003)
Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy.International journal of antimicrobial agents, 22 1
Kalayjian RC Landay A Pollard RB Taub DD Gross BH Francis IR et al
Age-related immune dysfunction in health and in human immunodeficiency
Allison Martin, M. Bloch, J. Amin, D. Baker, D. Cooper, S. Emery, A. Carr (2009)
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49 10
C. Hadigan, J. Meigs, C. Corcoran, Petra Rietschel, Sarah Piecuch, N. Basgoz, B. Davis, P. Sax, T. Stanley, P. Wilson, R. D'Agostino, S. Grinspoon (2001)
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32 1
K. Lichtenstein, C. Armon, K. Buchacz, J. Chmiel, Kern Buckner, E. Tedaldi, K. Wood, Scott D. Holmberg, J. Brooks (2010)
Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 51 4
C. Satchell, A. Cotter, E. O'Connor, A. Peace, A. Tedesco, A. Clare, J. Lambert, G. Sheehan, D. Kenny, P. Mallon (2010)
Platelet function and HIV: a case–control studyAIDS, 24
S. Holmberg, A. Moorman, J. Williamson, Tony Tong, D. Ward, K. Wood, A. Greenberg, R. Janssen (2002)
Protease inhibitors and cardiovascular outcomes in patients with HIV-1The Lancet, 360
Lang S Mary-Krause M Cotte L Gilquin J Partisani M Simon A et al
Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population.
R. Lange, L. Hillis (2001)
Cardiovascular complications of cocaine use.The New England journal of medicine, 345 5
(2010)
Abacavir induces human leukocyte endothelial cell interactions
B. Marin, R. Thiébaut, H. Bucher, V. Rondeau, D. Costagliola, M. Dorrucci, O. Hamouda, M. Prins, S. Walker, K. Porter, C. Sabin, G. Chêne (2009)
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyAIDS, 23
R. Kaplan, L. Kingsley, S. Gange, L. Benning, L. Jacobson, J. Lazar, K. Anastos, P. Tien, A. Sharrett, H. Hodis (2008)
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and menAIDS, 22
R. Amani, N. Sharifi (2012)
Cardiovascular Disease Risk Factors
Fabrice Bonnet, G. Chêne, Rodolphe Thiébaut, M. Dupon, S. Lawson-Ayayi, Jean-Luc Pellegrin, François Dabis, Philippe Morlat (2007)
Trends and determinants of severe morbidity in HIV‐infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004 *HIV Medicine, 8
N. Obel, D. Farkas, G. Kronborg, C. Larsen, G. Pedersen, A. Riis, Court Pedersen, J. Gerstoft, H. Sørensen, Henrik Sørensen (2010)
Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort studyHIV Medicine, 11
A. Carr, John Miller, M. Law, D. Cooper
FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome
ATP-III Panel.
Executive summary of the third report of the National Cholesterol Education
S. Wit, C. Sabin, R. Weber, S. Worm, P. Reiss, C. Cazanave, W. El-Sadr, A. Monforte, E. Fontas, M. Law, N. Friis‐Møller, A. Phillips (2008)
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected PatientsDiabetes Care, 31
K. Petoumenos, S. Worm, P. Reiss, S. Wit, A. Monforte, C. Sabin, N. Friis‐Møller, R. Weber, P. Mercié, C. Pradier, W. El-Sadr, O. Kirk, J. Lundgren, M. Law (2011)
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study *HIV Medicine, 12
P. Mallon, John Miller, D. Cooper, A. Carr (2003)
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapyAIDS, 17
I. Kriszbacher, M. Koppán, J. Bódis (2005)
Inflammation, atherosclerosis, and coronary artery disease.The New England journal of medicine, 353 4
S. Lang, M. Mary-Krause, L. Cotte, J. Gilquin, M. Partisani, A. Simon, F. Boccara, D. Costagliola (2010)
Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.Archives of internal medicine, 170 14
M. Wewers, J. Neidig, K. Kihm (2000)
The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers.The Journal of the Association of Nurses in AIDS Care : JANAC, 11 6
J. Tesoriero, S. Gieryic, A. Carrascal, Howard Lavigne (2010)
Smoking Among HIV Positive New Yorkers: Prevalence, Frequency, and Opportunities for CessationAIDS and Behavior, 14
J. Stebbing, Colin Wickenden, L. Castellano, A. Sita-Lumsden, Mark Nelson, J. Jacob, K. Naresh, Francesco Mauri, Mark Bower (2010)
No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancerAIDS, 24
M. Law, N. Friis‐Møller, W. El-Sadr, R. Weber, P. Reiss, A. Monforte, R. Thiébaut, L. Morfeldt, S. Wit, C. Pradier, G. Calvo, O. Kirk, C. Sabin, A. Phillips, J. Lundgren (2006)
The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D StudyHIV Medicine, 7
Phillips AN Carr A Neuhaus J Visnegarwala F Prineas R Burman WJ et al
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
Elizabeth Lloyd-Richardson, C. Stanton, G. Papandonatos, W. Shadel, M. Stein, K. Tashima, T. Flanigan, K. Morrow, C. Neighbors, R. Niaura (2009)
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.Addiction, 104 11
Friis-Moller N Thiebaut R Reiss P Weber R D’Arminio Monforte A De Wit S et al
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
N. Friis‐Møller, S. Worm (2007)
Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 45 8
Raymond Niaura, W. Shadel, Kathleen Morrow, Karen Tashima, Timothy Flanigan, David Abrams (2000)
Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 31 3
M. Mary-Krause, L. Cotte, A. Simon, M. Partisani, D. Costagliola (2003)
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected menAIDS, 17
M. Savès, G. Chêne, P. Ducimetiere, C. Leport, G. Moal, P. Amouyel, D. Arveiler, J. Ruidavets, J. Reynes, A. Bingham, F. Raffi (2003)
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 2
S. Lai, E. Fishman, H. Lai, Richard Moore, J. Cofrancesco, Harpreet Pannu, Wenjing Tong, Jiefu Du, J. Barlett (2008)
Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 4
D. Iosifescu, P. Renshaw, Kyoon Lyoo, Ho Lee, R. Perlis, G. Papakostas, Anderw Nierenberg (2001)
[Detection, evaluation, and treatment of high blood cholesterol in adults].Revista panamericana de salud publica = Pan American journal of public health, 9 5
J. Cook, J. Burke-Miller, Mardge Cohen, R. Cook, D. Vlahov, T. Wilson, E. Golub, R. Schwartz, A. Howard, C. Ponath, M. Plankey, Andrea Levine, Dennis Grey (2008)
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive womenAIDS, 22
C. Grunfeld, M. Pang, W. Doerrler, J. Shigenaga, P. Jensen, K. Feingold (1992)
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.The Journal of clinical endocrinology and metabolism, 74 5
D. Baarle, A. Tsegaye, F. Miedema, A. Akbar (2005)
Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system.Immunology letters, 97 1
R. Thiébaut, W. El-Sadr, N. Friis‐Møller, M. Rickenbach, P. Reiss, A. Monforte, L. Morfeldt, E. Fontas, O. Kirk, S. Wit, G. Calvo, M. Law, F. Dabis, C. Sabin, J. Lundgren (2005)
Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected PatientsAntiviral Therapy, 10
J. Currier, Anne Taylor, Felicity Boyd, C. Dezii, H. Kawabata, Beth Burtcel, J. Maa, S. Hodder (2003)
Coronary heart disease in HIV-infected individuals.Journal of acquired immune deficiency syndromes, 33 4
Lewis Kuller, R. Tracy, W. Belloso, S. Wit, F. Drummond, H. Lane, B. Ledergerber, J. Lundgren, Jacqueline Neuhaus, D. Nixon, Nicholas Paton, J. Neaton (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV InfectionPLoS Medicine, 5
M. Guimarães, D. Greco, S. Figueiredo, R. Fóscolo, Antônio Oliveira, L. Machado (2008)
High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.Atherosclerosis, 201 2
U. Iloeje, Yong Yuan, Gilbert L'Italien, Josephine Mauskopf, S. Holmberg, A. Moorman, Kathy Wood, Richard Moore (2005)
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patientsHIV Medicine, 6
M. May, J. Sterne, M. Shipley, E. Brunner, R. D'Agostino, P. Whincup, Y. Ben-Shlomo, A. Carr, B. Ledergerber, J. Lundgren, A. Phillips, J. Massaro, M. Egger (2007)
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.International journal of epidemiology, 36 6
R. Effros, C. Fletcher, K. Gebo, J. Halter, W. Hazzard, F. Horne, R. Huebner, E. Janoff, A. Justice, D. Kuritzkes, S. Nayfield, S. Plaeger, K. Schmader, J. Ashworth, C. Campanelli, C. Clayton, B. Rada, N. Woolard, K. High (2008)
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 47 4
A. Ross, Nesrine Rizk, M. O'riordan, V. Dogra, Dalia El-Bejjani, Norma Storer, Danielle Harrill, Marisa Tungsiripat, J. Adell, G. McComsey (2009)
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49 7
Wannamethee Sg, A. Shaper, P. Whincup, M. Walker (1995)
Smoking cessation and the risk of stroke in middle-aged men.JAMA, 274 2
J. Lundgren, M. Battegay, G. Behrens, S. Wit, G. Guaraldi, C. Katlama, E. Martínez, D. Nair, W. Powderly, P. Reiss, Jussi Sutinen, A. Viganò (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV *HIV Medicine, 9
S. Worm, S. Wit, R. Weber, C. Sabin, P. Reiss, W. El-Sadr, A. Monforte, O. Kirk, E. Fontas, F. Dabis, M. Law, J. Lundgren, N. Friis‐Møller (2009)
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)Circulation, 119
X. Duval, G. Baron, D. Garelik, V. Villes, T. Dupré, C. Leport, F. Lert, P. Peretti-Watel, P. Ravaud, B. Spire (2008)
Living with HIV, Antiretroviral Treatment Experience and Tobacco Smoking: Results from a Multisite Cross-Sectional StudyAntiviral Therapy, 13
S. Riddler, E. Smit, S. Cole, Rui Li, J. Chmiel, A. Dobs, F. Palella, B. Visscher, R. Evans, L. Kingsley (2003)
Impact of HIV infection and HAART on serum lipids in men.JAMA, 289 22
G. Lucas, L. Cheever, R. Chaisson, Richard Moore (2001)
Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 27
Fellay J Ledergerber B Bernasconi E Furrer H Battegay M Hirschel B et al
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.
Dube MP Stein JH Aberg JA Fichtenbaum CJ Gerber JG Tashima KT et al
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency
J. Grierson, R. Thorpe, Mark Saunders, M. Pitts (2004)
HIV futures 4: State of the (positive) nation
J. Currier, M. Kendall, W. Henry, Beverly Alston-Smith, F. Torriani, P. Tebas, Yanjie Li, H. Hodis (2007)
Progression of carotid artery intima–media thickening in HIV-infected and uninfected adultsAIDS, 21
N. Khuseyinova, W. Koenig (2012)
Predicting the Risk of Cardiovascular DiseaseMolecular Diagnosis & Therapy, 11
N. Godtfredsen, C. Holst, E. Prescott, J. Vestbo, M. Osler (2002)
Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies.American journal of epidemiology, 156 11
S. Worm, C. Sabin, R. Weber, P. Reiss, W. El-Sadr, F. Dabis, S. Wit, M. Law, A. Monforte, N. Friis‐Møller, O. Kirk, E. Fontas, I. Weller, A. Phillips, J. Lundgren (2010)
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.The Journal of infectious diseases, 201 3
Jesús Santos, R. Palacios, M. González, J. Ruiz, M. Márquez (2005)
Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study).International journal of STD & AIDS, 16 10
P. Wolf, R. D’Agostino, W. Kannel, R. Bonita, A. Belanger (1988)
Cigarette smoking as a risk factor for stroke. The Framingham Study.JAMA, 259 7
R. Kalayjian, A. Landay, R. Pollard, D. Taub, B. Gross, I. Francis, A. Sevin, Minya Pu, J. Spritzler, M. Chernoff, Ann Namkung, L. Fox, A. Martínez, K. Waterman, S. Fiscus, B. Sha, Debra Johnson, S. Slater, F. Rousseau, M. Lederman (2003)
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes.The Journal of infectious diseases, 187 12
T. Glass, C. Ungsedhapand, M. Wolbers, R. Weber, P. Vernazza, M. Rickenbach, H. Furrer, E. Bernasconi, M. Cavassini, B. Hirschel, M. Battegay, H. Bucher (2006)
Prevalence of risk factors for cardiovascular disease in HIV‐infected patients over time: the Swiss HIV Cohort StudyHIV Medicine, 7
Lundgren JD Battegay M Behrens G De Wit S Guaraldi G Katlama C et al
European AIDS Clinical
P. Ridker, N. Rifai, L. Rose, J. Buring, N. Cook (2002)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.The New England journal of medicine, 347 20
H. Ribaudo, C. Benson, Yu Zheng, S. Koletar, A. Collier, J. Lok, M. Smurzynski, R. Bosch, B. Bastow, J. Schouten (2011)
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 7
L. Normén, B. Yip, J. Montaner, J. Montaner, M. Harris, Jiri Frohlich, Jiri Frohlich, G. Bondy, G. Bondy, R. Hogg, R. Hogg (2007)
Use of metabolic drugs and fish oil in HIV‐positive patients with metabolic complications and associations with dyslipidaemia and treatment targetsHIV Medicine, 8
S. Bozzette, C. Ake, Henry Tam, Sophia Chang, T. Louis (2003)
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.The New England journal of medicine, 348 8
(2002)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation, 106 25
V. Triant, Hang Lee, C. Hadigan, S. Grinspoon (2007)
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.The Journal of clinical endocrinology and metabolism, 92 7
D. Klein, L. Hurley, C. Quesenberry, S. Sidney (2002)
Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV‐1 Infection?JAIDS Journal of Acquired Immune Deficiency Syndromes, 30
P. Wilson (2008)
Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.The American journal of medicine, 121 10 Suppl 1
For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group
Kathleen Fitch, E. Anderson, J. Hubbard, Sara Carpenter, W. Waddell, A. Caliendo, S. Grinspoon (2006)
Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndromeAIDS, 20
C. Smith, I. Levy, C. Sabin, E. Kaya, MA. Johnson, M. Lipman (2004)
Cardiovascular disease risk factors and antiretroviral therapy in an HIV‐positive UK populationHIV Medicine, 5
W. Taylor, N. Unwin (2009)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
S. Mallal, M. John, C. Moore, I. James, E. McKinnon (2000)
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infectionAIDS, 14
Edward Mamary, D. Bahrs, Sharon Martinez (2002)
Cigarette smoking and the desire to quit among individuals living with HIV.AIDS patient care and STDs, 16 1
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, A. Rumley, G. Lowe (2001)
Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-AnalysisCirculation: Journal of the American Heart Association, 103
J. Lundgren (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patientsAIDS, 22
J. Currier, J. Lundgren, A. Carr, D. Klein, C. Sabin, P. Sax, J. Schouten, M. Smieja (2008)
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.Circulation, 118 2
E. Madden, Grace Lee, D. Kotler, C. Wanke, C. Lewis, R. Tracy, S. Heymsfield, M. Shlipak, P. Bacchetti, R. Scherzer, C. Grunfeld (2008)
Association of antiretroviral therapy with fibrinogen levels in HIV-infectionAIDS, 22
V. Triant, S. Regan, Hang Lee, P. Sax, J. Meigs, S. Grinspoon (2010)
Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare SystemJAIDS Journal of Acquired Immune Deficiency Syndromes, 55
De Wit S Sabin CA Weber R Worm SW Reiss P Cazanave C et al
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
G. Prestage, F. Jin, S. Kippax, I. Zablotska, J. Imrie, A. Grulich (2009)
Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia.The journal of sexual medicine, 6 8
R. Kaplan, L. Kingsley, A. Sharrett, Xiuhong Li, J. Lazar, P. Tien, P. Tien, W. Mack, Mardge Cohen, L. Jacobson, S. Gange (2007)
Ten-year predicted coronary heart disease risk in HIV-infected men and women.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 45 8
P. Hsue, J. Lo, Arlana Franklin, A. Bolger, Jeffrey Martin, S. Deeks, D. Waters (2004)
Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV InfectionCirculation: Journal of the American Heart Association, 109
A. Tverdal, Dag Thelle, I. Stensvold, P. Leren, K. Bjartveit (1993)
Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years.Journal of clinical epidemiology, 46 5
A. Bénard, F. Bonnet, J. Tessier, H. Fossoux, M. Dupon, P. Mercié, J. Ragnaud, J. Viallard, F. Dabis, G. Chêne (2007)
Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort.AIDS patient care and STDs, 21 7
W. El-Sadr, W. El-Sadr, J. Lundgren, J. Neaton, F. Gordin, D. Abrams, R. Arduino, A. Babiker, W. Burman, N. Clumeck, C. Cohen, D. Cohn, D. Cooper, J. Darbyshire, S. Emery, G. Fätkenheuer, B. Gazzard, B. Grund, J. Hoy, K. Klingman, M. Losso, N. Markowitz, J. Neuhaus, A. Phillips, C. Rappoport (2006)
CD4+ count-guided interruption of antiretroviral treatment.The New England journal of medicine, 355 22
J. Baker, J. Baker, Jacqueline Neuhaus, D. Duprez, L. Kuller, R. Tracy, W. Belloso, S. Wit, F. Drummond, H. Lane, B. Ledergerber, J. Lundgren, D. Nixon, N. Paton, J. Neaton (2011)
Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 56
K. Crothers, J. Goulet, M. Rodriguez‐Barradas, C. Gibert, A. Butt, R. Braithwaite, Robin Peck, A. Justice (2007)
Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative VeteransJournal of General Internal Medicine, 22
N. Friis‐Møller, R. Weber, P. Reiss, R. Thiébaut, O. Kirk, A. Monforte, C. Pradier, L. Morfeldt, S. Mateu, M. Law, W. El-Sadr, S. Wit, C. Sabin, A. Phillips, J. Lundgren (2003)
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS, 17
A. Viganò, G. Bedogni, C. Cerini, L. Meroni, V. Giacomet, S. Stucchi, V. Fabiano, S. Coletto, M. Catalano, M. Minola, G. Zuccotti (2010)
Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults.Current HIV research, 8 5
B. Lau, A. Sharrett, L. Kingsley, W. Post, F. Palella, B. Visscher, S. Gange (2006)
C-reactive protein is a marker for human immunodeficiency virus disease progression.Archives of internal medicine, 166 1
Nevenka Čop-Blažić (2002)
Pušenje kao čimbenik rizika za moždani udarActa Clinica Croatica, 41
J. Murray, A. McDonald, M. Law (2009)
Rapidly ageing HIV epidemic among men who have sex with men in Australia.Sexual health, 6 1
(2011)
No association of myocardial infarction with ABC use: an FDA Meta-analysis
In the developed world, HIV infection is now well managed with very effective and less toxic antiretroviral treatment. HIV-positive patients therefore are living longer, but are now faced by challenges associated with aging. Several non-AIDS associated morbidities are increased in this population, including cardiovascular disease (CVD). It is suggested that CVD occurs earlier among HIV-positive patients compared with HIV-negative patients, and at a higher rate. Several factors have been proposed to contribute to this. First, the traditional CVD risk factors are highly prevalent in this population. High rates of smoking, dyslipidaemia and a family history of CVD have been reported. This population is also aging, with estimates of more than 25% of HIV-positive patients in the developed world being over the age of 50. Antiretroviral treatment, both through its effect on lipids and through other, sometimes less well understood, mechanisms, has been linked to increased CVD risk. HIV infection, especially untreated, is a further contributing factor to increased CVD risk in HIV-positive patients. As the HIV-positive population continues to age, the risk of CVD will continue to increase. Guidelines for the management and prevention of CVD risk have been developed, and are largely modelled on those used in the general population. However, the data currently suggest that these interventions, such as the use of lipid-lowering medications and smoking cessation programs, remain quite low. A better understanding the mechanisms of CVD risk in this aging population and further efforts in improving uptake of prevention strategies will remain an important research area.
Sexual Health – CSIRO Publishing
Published: Jul 29, 2011
Keywords: AIDS, antiretroviral treatment, dislipidaemia, heart disease, myocardial infarction.
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.